IRIS
PICCIOTTO, ANTONINO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 11.538
AS - Asia 1.072
NA - Nord America 809
SA - Sud America 91
AF - Africa 20
OC - Oceania 3
Totale 13.533
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 11.377
US - Stati Uniti d'America 744
SG - Singapore 443
CN - Cina 269
VN - Vietnam 174
BD - Bangladesh 89
FR - Francia 84
BR - Brasile 55
HK - Hong Kong 33
CA - Canada 26
FI - Finlandia 23
AR - Argentina 17
JP - Giappone 17
MX - Messico 17
DE - Germania 12
IQ - Iraq 9
IN - India 8
NL - Olanda 8
CH - Svizzera 7
GB - Regno Unito 7
ZA - Sudafrica 6
HN - Honduras 5
KR - Corea 5
MA - Marocco 5
VE - Venezuela 5
JM - Giamaica 4
PE - Perù 4
AU - Australia 3
CO - Colombia 3
CR - Costa Rica 3
EC - Ecuador 3
IE - Irlanda 3
JO - Giordania 3
KE - Kenya 3
PH - Filippine 3
TT - Trinidad e Tobago 3
BY - Bielorussia 2
CL - Cile 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ID - Indonesia 2
LT - Lituania 2
MD - Moldavia 2
PS - Palestinian Territory 2
PT - Portogallo 2
RU - Federazione Russa 2
SA - Arabia Saudita 2
TH - Thailandia 2
TR - Turchia 2
UA - Ucraina 2
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
EG - Egitto 1
ES - Italia 1
ET - Etiopia 1
GT - Guatemala 1
HR - Croazia 1
HT - Haiti 1
KZ - Kazakistan 1
LB - Libano 1
MY - Malesia 1
NI - Nicaragua 1
PK - Pakistan 1
PR - Porto Rico 1
RO - Romania 1
RW - Ruanda 1
SC - Seychelles 1
SI - Slovenia 1
SV - El Salvador 1
TJ - Tagikistan 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 13.533
Salva come PNG Salva come JPEG
Città #
Genova 7.457
Genoa 2.233
Rapallo 954
Vado Ligure 647
San Jose 250
Singapore 198
Lauterbourg 80
Ashburn 68
Ho Chi Minh City 51
New York 43
Beijing 38
Hanoi 34
Hong Kong 31
Santa Clara 23
Helsinki 22
Council Bluffs 21
Los Angeles 20
Tokyo 15
Milan 12
Bordighera 11
Chicago 10
Frankfurt am Main 10
Mexico City 9
Rome 9
Buffalo 8
Da Nang 8
Dallas 7
Orem 7
Tianjin 7
Zurich 7
Amsterdam 6
Haiphong 6
Montreal 6
Toronto 6
Atlanta 5
Houston 5
Phoenix 5
San Francisco 5
Biên Hòa 4
Charlotte 4
Naples 4
São Paulo 4
Brooklyn 3
Bình Dương 3
Des Moines 3
Detroit 3
Dublin 3
Gaithersburg 3
Guangzhou 3
Hải Dương 3
Las Vegas 3
Mosul 3
Richmond 3
San José 3
Sorocaba 3
Thái Nguyên 3
Ahmedabad 2
Akron 2
Alexandria 2
Alpharetta 2
Amman 2
Baltimore 2
Baton Rouge 2
Boardman 2
Bogotá 2
Bắc Giang 2
Bắc Ninh 2
Cabo Frio 2
Cape Town 2
Charleston 2
Dahlonega 2
DeLand 2
Erie 2
Fayetteville 2
Florence 2
Fontana 2
Fresno 2
Johannesburg 2
Kingston 2
Knoxville 2
London 2
Lấp Vò 2
Memphis 2
Miami 2
Minsk 2
Nairobi 2
Omaha 2
Orland Park 2
Pflugerville 2
Philadelphia 2
Princeton 2
Quito 2
Quận Ba 2
Rio de Janeiro 2
San Fernando 2
San Mateo 2
Shenzhen 2
St Louis 2
Sterling Heights 2
Sydney 2
Totale 12.480
Salva come PNG Salva come JPEG
Nome #
Non-antigen-specific CD8(+) T suppressor lymphocytes in diseases characterized by chronic immune responses and inflammation. 278
Autoimmune intrahepatic cholangiopathy associated with antiphospholipid antibody syndrome 229
A new assay for hepatitis C virus (HCV) core antigen detection: an alternative to nucleic acid technologies in positive or indeterminate anti-HCV subjects? 223
Hepatitis G virus infection in haemodialysis and in peritoneal dialysis patients. 222
Epidemiological and clinical features of hepatitis delta in HBsAg-positive patients by HIV status. 210
'Emergency exit' of bone-marrow-resident CD34+ DNAM-1 bright CXCR4+-committed lymphoid precursors during chronic infection and inflammation 206
Circadian monitoring of gastric juice mutagenicity. 201
Measurement of sorafenib plasma concentration by high-performance liquid chromatography in patients with advanced hepatocellular carcinoma: is it useful the application in clinical practice? A pilot study 198
Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis 198
Behavior of soluble HLA class I antigens in patients with chronic hepatitis C during interferon therapy: an early predictor marker of response? 196
S-adenosil-L-methionine is able to reverse the immunosuppressive effects of chenodeoxycholic acid in vitro. 189
Behavior of soluble HLA-A, -B, -C and HLA-G molecules in patients with chronic hepatitis C virus infection undergoing pegylated interferon-α and ribavirin treatment: potential role as markers of response to antiviral therapy 187
Anti-hepatitis C virus antibodies and hepatitis C virus viraemia in haemodialysis patients 186
Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment. 184
Peginterferon alfa-2b and Ribavirin: Effective in Patients With Hepatitis C Who Failed Interferon alfa/Ribavirin Therapy. 182
Peripheral blood cytopaenia limiting initiation of treatment in chronic hepatitis C patients otherwise eligible for antiviral therapy 181
Biopsychosocial predictors of interferon-related depression in patients with Hepatitis C 180
Circadian reduction of chromium in the gastric environment. 178
A case of drug rash with eosinophilia and systemic symptoms (DRESS) induced by telaprevir associated with HHV-6 active infection 175
Peripheral blood serum markers for apoptosis and liver fibrosis: Are they trustworthy indicators of liver realness? 172
T cells from patients with chronic liver diseases: abnormalities in PHA-induced expression of HLA class II antigens and in autologous mixed-lymphocyte reactions. 172
Liver transplantation in type III von Willebrand disease 172
Mutagenicity of cimetidine in nitrite-enriched human gastric juice. 166
Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients 165
Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy. 163
Comparison between laparoscopy, ultrasonography, and computed tomography in widespread and localized liver diseases. 162
Successful antiviral therapy determines a significant decrease in squamous cell carcinoma antigen-associated (SCCA) variants' serum levels in anti-HCV positive cirrhotic patients. 161
Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis 161
Soluble apoptosis molecules in primary biliary cirrhosis: analysis and commitment of the Fas and tumour necrosis factor-related apoptosis-inducing ligand systems in comparison with chronic hepatitis C. 160
Prevalence and Undertreatment of Prothrombotic Risk in Advanced Forms of Liver Disease 159
Interferon retreatment in chronic hepatitis C: wich patients to choose, and what schedule to use 158
A single-blind pilot study comparing standard and half bedtime doses of ranitidine in the short-term healing of duodenal ulcer. 158
Antiviral activity of amantadine in elderly patients with chronic hepatitis C 158
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 158
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. 156
Single bedtime dose of famotidine: assessment of its antisecretory action by 24-hour intragastric pH monitoring. 154
Clearance kinetics of hepatitis C virus under different antiviral therapies. 154
Is hepatic ultrasonography a valid alternative tool to liver biopsy? Report on 507 cases studied with both techniques. 152
Inherent transcriptional signatures of NK cells are associated with response to IFNΑ+rivabirin therapy in patients with Hepatitis C Virus 152
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 152
Clinical and virological survey of patients with hepatitis B surface antigen in an Italian region: clinical considerations and disease burden 151
Increased beta2-microglobulin-free HLA class I heavy chain serum levels in the course of immune responses to viral antigens and to mismatched HLA antigens. 148
Are clinical patterns of dyspepsia a valid guideline for appropriate use of endoscopy? A report on 2253 dyspeptic patients. 146
Continuous lamivudine treatment in an OLT patient despite the appearance of HBV resistant strain: longitudinal analysis. 146
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 146
Treatment of hepatitis C virus infection with direct-acting antiviral drugs is safe and effective in patients with hemoglobinopathies 145
A significant proportion of patients with chronic hepatitis B who are candidates for antiviral treatment are untreated: a region-wide survey in Italy 144
Monotherapy with Pegylated Interferon Alpha-2a in Hemodialyzed Patients with Chronic Hepatitis C 142
Predictive factors for response to Peginterferon-Alpha and ribavirin treatment of chronic HCV infection in patients aged 65 years and more 142
Virological and biochemical responses to interferon-a in chronic hepatitis C 140
HOMA, BMI, and serum leptin levels variations during antiviral treatment suggest virus-related insulin resistance in noncirrhotic, nonobese, and nondiabetic chronic hepatitis C genotype 1 patients 140
Pegylated interferon and ribavirin in re-treatment of responder-relapser HCV patients. 139
Long-term interferon alfa-2b retreatment of relapsing patients with chronic hepatitis C. 138
Porphyrin Elevation in a Patient on Treatment With Simeprevir: Could It Be a Possible Explanation for Simeprevir-Associated Photosensitivity? 138
Medical report type in liver transplantation as a quality system document: new prospects for computerization. 136
Effects of Interferon therapy on monoethylglycinexylidide formation in patients with chronic active hepatitis C 135
Hepatic Elastometry and Glissonian Line in the Assessment of Liver Fibrosis 135
Elevations in ALT levels late the course of antiviral therapy in HCV-RNA negative patients are associated with virological relapse 132
Kinetics of soluble tumour necrosis factor (TNF)-alpha receptors and cytokines in the early phase of treatment for chronic hepatitis C: comparison between interferon (IFN)-alpha alone, IFN-alpha plus amantadine or plus ribavirin. 131
Prospective evaluation of primary infection due to HCV, HGV or TTV in children with newly diagnosed neoplasia. 130
TT virus infection in haemodialysis patients 130
Chronic hepatitis C. New therapeutic strategies. 127
The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation: A national real-life experience 127
Soluble tumor necrosis factor-related ligand (sTRAIL) levels and kinetics during antiviral treatment in chronic hepatitis C 126
Amantadine: a different approach. 125
First experimental proof of Proton Boron Capture Therapy (PBCT) to enhance protontherapy effectiveness 125
Serum lamivudine levels in the presence of a lamivudine-resistant HBV mutant 124
Sustained virological response to pegylated interferon and ribavirin is maintained during long-term follow-up of chronic hepatitis C patients. 124
Macroamylasemia: a possible cause of unexplained hyperamylasemia in rheumatoid arthritis. 123
Use of Victoria blue in the detection of intrahepatocyte HBs Ag: comparison with other methods. 121
Hepatitis C in the elderly: A multicentre cross-sectional study by the Italian Association for the Study of the Liver 121
Diabetic hepatosclerosis presenting with severe cholestasis 119
Predictive value of on-treatment response during full-dose antiviral therapy of patients with hepatitis C virus cirrhosis and portal hypertension. 118
Interferon beta-1a alone or in combination with ribavirin: a randomized trial to compare efficacy and safety in chronic hepatitis C. 117
Therapeutic management of chronic hepatitis B in clinical Practice: a region-wide survey. 117
Biochemical scores could reflect histological activity in chronic hepatitis C 117
EVALUATION OF HEPATIC FIBROSIS WITH TRANSIENT ELASTOGRAPHY (FIBROSCAN) AND APRI SCORE IN PATIENTS WITH SYSTEMIC SCLEROSIS AND ITS CORRELATION WITH PULMONARY, CARDIAC, RENAL AND ESOPHAGEAL INVOLVEMENT 116
Initial high dose of lamivudine delays the appearance of viral resistance in chronic hepatitis B patients 104
Serum intercellular adhesion molecule-1 and long-term response to IFN-alpha2b therapy in chronic hepatitis C 104
Evaluation of a new hepatitis C virus sequecing assay as a routine method for genotyping 103
Cost-effectiveness of pretransplant sofosbuvir for preventing recurrent hepatitis C virus infection after liver transplantation 103
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. 101
Effect of a common missense variant in LIPA gene on fatty liver disease and lipid phenotype: New perspectives from a single-center observational study 101
Hepatitis C recurrence: Split liver versus whole size graft. 100
Predictability and survival in liver replantransplantation: Monocentric experience 99
Probability of non-response during interferon therapy in patients with chronic hepatitis C 95
Pityriasis rosea in a hepatitis b-positive patient treated with pegylated interferon α2a: Report of a case and review of the literature 92
Postprandial serum bile acids after ursodeoxycholic acid. A possible test of intestinal absorption? 91
Metabolic activation of food hepatocarcinogens in hepatitis B virus-infected humans and animals. 90
Detection of anti-HCV IgM antibodies in patients with chronic hepatitis C treated with interferon 89
Iodized oil pleural effusion in a patient previously treated with transarterial chemoembolization for hepatocellular carcinoma 87
Soluble beta2-mu-associated and beta2-mu-free HLA class I heavy chain serum levels in interferon-alpha nonresponder chronic hepatitis C patients. Markers of immune activation, and response to antiviral retreatment. 77
Role of dietary intervention in patients with metabolic syndrome and {NAFLD}-{NASH} 72
Individualized treatment of genotype 1 Naïve patients: An Italian multicenter field practice experience 68
Totale 13.625
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.659
article - articoli 41.149
book - libri 0
conference - conferenze 510
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.318
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.168 36 63 73 145 47 81 69 262 92 104 47 149
2022/20231.134 115 105 11 107 175 192 3 95 205 11 105 10
2023/2024463 19 80 8 59 32 63 25 30 30 9 40 68
2024/20251.574 52 106 35 108 248 154 138 279 51 59 148 196
2025/20262.707 374 53 122 191 347 268 417 121 178 243 162 231
2026/2027203 203 0 0 0 0 0 0 0 0 0 0 0
Totale 13.625